Related Experiment Video
Updated: Aug 19, 2026

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
Published on: February 18, 2016
Behavioural effects of long term inhibition of 5-hydroxytryptamine receptors using metergoline
Abstract:
1. Rats were treated with acute and chronic schedules of metergoline (2.5 mg/kg I.P. twice daily) and acutely with dl-propranolol (15 mg/kg), amitriptyline (12.5 mg/kg) and fluoxetine (2 mg/kg). 2. Metergoline given both acutely and chronically blocked the behavioural response to the 5-hydroxytryptamine receptor agonist 5-methoxy-N1, N1-dimethyltryptamine (5MeODMT) (2.5 mg/kg I.P.). The response to 5MeODMT) was also blocked by acute administration of dl-propranolol and amitriptyline, but not fluoxetine. 3. Rats given chronic treatment with metergoline and then withdrawn from drug treatment for 3 days showed an enhanced response to 5MeODMT. 4. Chronic metergoline treatment caused an increase in ambulatory movement following 5MeODMT administration. 5. Exploratory behaviour, when measured under dark conditions, was reduced by chronic metergoline treatment. 6. The results suggest that supersensitivity to 5-hydroxytryptamine agonists can be induced by chronic treatment with an antagonist. Furthermore, metergoline and 5-methoxy-N1, N1-dimethyltryptamine may not act on identical receptor populations.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting Neurotransmitter Release or Uptake
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

